‘Regulatorism': A New Terminology For Medtech And Pharmaceutical Leadership Mindsets

Thoughts From Jack Wong, Secretary And Founder Of The Asia Regulatory Professional Association

The new regulatory professionalism drive sweeping over the global medtech and pharmaceutical sectors will lead to better value for all health care stakeholders. This is of particular relevance in regions such as Asia, where regulatory manpower is often at low levels. 

Regulation

Regulatory affairsroles are the means by which companies ensure that they comply with the regulations and laws pertaining to their business. These roles are vital in making safe and effective health care products available worldwide.

The responsibilities of an RA executive often begin right at the start of a product’s R&D phase, and continue through clinical trials and into premarket approval activities, manufacturing, labeling and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Global Vision

More from In Vivo